For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
12
views
0
references
 Top references
cited by
3
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      1,760
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      AGO-OVAR 12: a randomized placebo controlled GCIGENGOT intergroup phase III trial of standard frontline chemotherapy nintedanib for advanced ovarian cancer.

      Author(s):
      Publication date:
      Journal: Int J Gynecol Cancer

      Read this article at

      ScienceOpen
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Data availability:
          ScienceOpen disciplines: Oncology & Radiotherapy, Medicine

          Comments

          Comment on this article